The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Sexually Transmitted Infections (STIs) Market In 2026 And What Value Is Projected For 2030?
The market size for sexually transmitted infections (STIs) has seen rapid growth over recent years. It is anticipated to expand from $71.28 billion in 2025 to $79.48 billion in 2026, with a compound annual growth rate (CAGR) of 11.5%. This historical growth can be attributed to the rising incidence of STIs, restricted availability of early diagnostic instruments, the expansion of government-led awareness campaigns, evolving urbanization and lifestyle choices, and an increase in patient consultations at sexual health clinics.
The market size for sexually transmitted infections (stis) is projected to experience rapid expansion in the coming years, with an anticipated growth to $126.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.4%. This expected growth during the forecast period is attributable to several factors, including the adoption of advanced molecular diagnostics, an increase in at-home STI testing, growing integration with telemedicine platforms, enhanced funding for STI prevention programs, and the rise of AI-assisted diagnostic tools. Major trends foreseen in this period encompass the development of rapid point-of-care STI testing, increasing utilization of home-based STI test kits, a surge in vaccine development for STIs, broader adoption of combination diagnostic platforms, and expanding public awareness campaigns focused on STI prevention.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Sexually Transmitted Infections (STIs) Market?
The sexually transmitted infections (STIs) market is expected to experience growth driven by the rising number of government initiatives aimed at raising awareness about these infections. A government initiative represents a program or policy put into action to achieve a specific goal and address particular challenges. Governments introduce various measures to prevent, control, and treat sexually transmitted infections (STIs), including funding public education campaigns to boost STI awareness, offering vaccines to prevent certain STIs, and providing free or low-cost screening and testing services. For instance, in April 2023, Springfield-Greene County Health, a US-based public health department, launched the Disease Intervention Specialist (DIS) program. This new initiative, a partnership with the Missouri Department of Health and Senior Services (Missouri DHSS), was created to combat the increasing spread of sexually transmitted infections (STIs) in Greene County. The two experts within the DIS program will primarily focus on syphilis and HIV, contacting individuals who test positive for these diseases, connecting them with treatment options, and helping to identify and notify others who may be affected by the infection. Consequently, the increase in government initiatives will propel the sexually transmitted infections (STIs) market.
What Are The Key Segments Of The Sexually Transmitted Infections (STIs) Market?
The sexually transmitted infections (stis) market covered in this report is segmented –
1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types
2) By Treatment: Antibiotics, Antiviral
3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2
2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV
3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea
4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis
5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis
Which Trends Are Shaping The Future Of The Sexually Transmitted Infections (STIs) Market?
Major companies operating in the sexually transmitted infections (STIs) market are developing innovative products utilizing fluorescent PCR technology to gain a competitive advantage. Fluorescent PCR (Polymerase Chain Reaction) technology is a molecular biology technique designed to detect and quantify specific DNA sequences within a biological sample. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of molecular diagnostic solutions, introduced two new polymer chain reaction (PCR) kits: the Mycoplasma Hominis Real-Time PCR Kit and the Treponema Pallidum Real-Time PCR Kit. These Kits provide a complete PCR solution for the early diagnosis of sexually transmitted illnesses, which affect numerous individuals. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent that uses fluorescent PCR technology to detect Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs, and urine samples. The BioPerfectus Treponema Pallidum Real-Time PCR Kit is designed to detect treponema pallidum nucleic acid in human serum and plasma.
Who Are The Leading Companies Operating In The Sexually Transmitted Infections (STIs) Market?
Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy’s Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.
Read the full sexually transmitted infections (stis) market report here:
What Are The Leading Geographic Regions In The Sexually Transmitted Infections (STIs) Market?
North America was the largest region in the sexually transmitted infection (STIs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted infections (stis) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Sexually Transmitted Infections (STIs) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13047&type=smp
Browse Through More Reports Similar to the Global Sexually Transmitted Infections (STIs) Market 2026, By The Business Research Company
Std Diagnostics Global Market Report
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report
Chlamydia Infection Diagnostics Global Market Report
Genital Herpes Global Market Report
https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model